2020
DOI: 10.21873/anticanres.14366
|View full text |Cite
|
Sign up to set email alerts
|

Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer

Abstract: Background/Aim: Apoptotic peptidase activating factor 1 (APAF-1) is essential regulator of apoptosis and inactivation by DNA methylation is common event in numerous cancer types. We investigated the regulation of APAF-1 through DNA methylation in pancreatic cancer. Materials and Methods: Datasets from 44 patients after pancreatoduodenectomy and the pancreatic adenocarcinoma (PDAC) cell lines Capan-2 and MIA PaCa-2 treated with decitabine were analyzed by RT-PCR, immunoblotting, methylation-specific PCR analysi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…While this is cell biologically very interesting, it raises a fundamental question: in which situation does such inflammatory cell death occur? There are a few reports where caspase-activation in cancer cells may be altered, mostly by down-regulation of Apaf-1 in melanoma (although with unknown frequency [ 12 ]) and in pancreatic cancer [ 13 ], and cardiomyocytes have been reported to express little Apaf-1 and to generate only low caspase-activity [ 14 ]. However, a lack of caspases or a block of caspase-activation downstream of mitochondria seems very rare in human cells, and the non-inflammatory nature of apoptotic cell death has for decades been regarded as a hallmark of apoptosis [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…While this is cell biologically very interesting, it raises a fundamental question: in which situation does such inflammatory cell death occur? There are a few reports where caspase-activation in cancer cells may be altered, mostly by down-regulation of Apaf-1 in melanoma (although with unknown frequency [ 12 ]) and in pancreatic cancer [ 13 ], and cardiomyocytes have been reported to express little Apaf-1 and to generate only low caspase-activity [ 14 ]. However, a lack of caspases or a block of caspase-activation downstream of mitochondria seems very rare in human cells, and the non-inflammatory nature of apoptotic cell death has for decades been regarded as a hallmark of apoptosis [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…As numerous studies have shown, colon adenocarcinoma is not the only cancer type to have reduced expression of Apaf-1 protein. Lukosiute-Urbonieniehas shown that in pancreatic ductal adenocarcinoma (PDAC) downregulation of Apaf-1 expression was detected both at mRNA and protein levels [24]. Decreased level of Apaf-1 was also found in serum samples of patients [25].…”
Section: Discussionmentioning
confidence: 95%
“…Moreover, the DNA methylation of the CDKN2A promoter was a more frequent event in aggressive prostatic tumors with PNI [41]. Several other studies demonstrated an association between the epigenetic regulation of specific candidate genes by altered DNA methylation and the development of PNI [42][43][44][45][46][47][48][49][50]. Still, the DNA methylation status in head and neck squamous cell carcinoma has not yet been studied sufficiently [50].…”
Section: Discussionmentioning
confidence: 99%